ACCD - Accolade, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Plymouth Meeting,
United States
Type: Equity
ACCD price evolution
ACCD
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $230.02 | $292.19 | $302.87 | |
| Short term investments | ||||
| Net receivables | $25.56 | $25.31 | $26.3 | |
| Inventory | ||||
| Total current assets | $272.09 | $336.26 | $348.47 | |
| Long term investments | ||||
| Property, plant & equipment | $48.07 | $44.44 | $44.69 | |
| Goodwill & intangible assets | $452.74 | $461.88 | $471.02 | |
| Total noncurrent assets | $513.38 | $518.06 | $527.23 | |
| Total investments | ||||
| Total assets | $785.47 | $854.32 | $875.71 | |
| Current liabilities | ||||
| Accounts payable | $21.75 | $17.23 | $20.22 | |
| Deferred revenue | $52.89 | $47.62 | $44.33 | |
| Short long term debt | $6.9 | $6.36 | $6.92 | |
| Total current liabilities | $115.67 | $109 | $112.74 | |
| Long term debt | $234.8 | $307.41 | $308.48 | |
| Total noncurrent liabilities | $235.08 | $307.67 | $308.79 | |
| Total debt | $241.7 | $313.77 | $315.4 | |
| Total liabilities | $350.75 | $416.68 | $421.53 | |
| Shareholders' equity | ||||
| Retained earnings | -$1046.59 | -$1025.53 | -$992.7 | |
| Other shareholder equity | ||||
| Total shareholder equity | $434.72 | $437.64 | $454.18 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $321.08 | $365.85 | $433.88 | $33.16 |
| Short term investments | ||||
| Net receivables | $26.7 | $30.8 | $11.84 | $1.19 |
| Inventory | ||||
| Total current assets | $365.95 | $409.14 | $453.98 | $48.94 |
| Long term investments | ||||
| Property, plant & equipment | $44.29 | $44.92 | $9.23 | $13.63 |
| Goodwill & intangible assets | $481.39 | $822.59 | $4.62 | $6.07 |
| Total noncurrent assets | $537.12 | $876.39 | $21.53 | $24.31 |
| Total investments | ||||
| Total assets | $903.07 | $1285.53 | $475.51 | $73.25 |
| Current liabilities | ||||
| Accounts payable | $25.85 | $24.1 | $12.4 | $9.95 |
| Deferred revenue | $35.34 | $31.14 | $26.27 | $29.32 |
| Short long term debt | $7.28 | $6.59 | ||
| Total current liabilities | $119.41 | $111.75 | $79.08 | $69.96 |
| Long term debt | $309.51 | $313.15 | $280.67 | $21.14 |
| Total noncurrent liabilities | $309.87 | $317.98 | $5.59 | $27.06 |
| Total debt | $316.8 | $319.74 | $21.14 | |
| Total liabilities | $429.28 | $429.74 | $84.66 | $97.02 |
| Shareholders' equity | ||||
| Retained earnings | -$954.29 | -$494.64 | -$371.52 | -$320.87 |
| Other shareholder equity | ||||
| Total shareholder equity | $473.79 | $855.79 | $390.85 | -$256.8 |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $96.86 | |||
| Cost of revenue | $55.32 | |||
| Gross Profit | $41.55 | |||
| Operating activities | ||||
| Research & development | $25.6 | |||
| Selling, general & administrative | $40.34 | |||
| Total operating expenses | $76.75 | |||
| Operating income | -$35.21 | |||
| Income from continuing operations | ||||
| EBIT | -$34.45 | |||
| Income tax expense | $0.08 | |||
| Interest expense | -$1.71 | |||
| Net income | ||||
| Net income | -$32.83 | |||
| Income (for common shares) | -$32.83 | |||
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $363.14 | $170.36 | $132.51 | |
| Cost of revenue | $198.91 | $93.67 | $73.69 | |
| Gross Profit | $164.24 | $76.69 | $58.82 | |
| Operating activities | ||||
| Research & development | $101.35 | $49.95 | $42.31 | |
| Selling, general & administrative | $180.32 | $65.3 | $56.2 | |
| Total operating expenses | $627.77 | $123.61 | $107.13 | |
| Operating income | -$463.53 | -$46.92 | -$48.31 | |
| Income from continuing operations | ||||
| EBIT | -$463.53 | -$46.92 | -$48.31 | |
| Income tax expense | -$3.62 | $0 | $0.13 | |
| Interest expense | -$0.26 | $3.72 | $2.92 | |
| Net income | ||||
| Net income | -$459.65 | -$50.65 | -$51.37 | |
| Income (for common shares) | -$459.65 | -$50.65 | -$51.37 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$21.06 | -$32.83 | -$38.41 | -$30.43 |
| Operating activities | ||||
| Depreciation | $11.4 | $10.82 | $11.64 | $11.63 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $15.64 | $15.73 | $14.28 | $17.84 |
| Total cash flows from operations | $5.21 | -$8.04 | -$19.29 | -$2.56 |
| Investing activities | ||||
| Capital expenditures | -$3.71 | -$3.29 | -$3.38 | -$2.41 |
| Investments | ||||
| Total cash flows from investing | -$3.71 | -$3.29 | -$3.38 | -$2.41 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.5 | $0.64 | $4.45 | $0.42 |
| Net borrowings | -$66.16 | |||
| Total cash flows from financing | -$63.66 | $0.64 | $4.45 | $0.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$62.17 | -$10.68 | -$18.21 | -$4.55 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$459.65 | -$123.12 | -$50.65 | -$51.37 |
| Operating activities | ||||
| Depreciation | $46.38 | $42.61 | $8.21 | $8.52 |
| Business acquisitions & disposals | -$260 | -$0.06 | -$0.21 | |
| Stock-based compensation | $72.64 | $72.94 | $9.58 | $11.89 |
| Total cash flows from operations | -$40.7 | -$62.35 | -$25.23 | -$34.25 |
| Investing activities | ||||
| Capital expenditures | -$7.23 | -$3.62 | -$2.37 | -$3.31 |
| Investments | ||||
| Total cash flows from investing | -$7.23 | -$263.61 | -$2.42 | -$3.52 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.99 | $13.3 | $451.14 | $6.62 |
| Net borrowings | $279.13 | -$22.75 | $1.66 | |
| Total cash flows from financing | $3.16 | $257.93 | $428.38 | $28.22 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$44.77 | -$68.03 | $400.73 | -$9.55 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.91 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |